Today is International Day of Radiology. We would like to recognize all the medical imaging professionals who play a pivotal role in diagnosing through the interpretation of essential imaging, such as #X-rays, #Ultrasound, #MRI, and #CTscans. Medical imaging is crucial in using our products, leading to better patient outcomes and proper treatment. #InternationalDayofRadiology #IDOR2024 #medicalimaging Risk Info: https://lnkd.in/gFNG_pA AngioDynamics and the AngioDynamics logo are trademarks and/or registered trademarks of AngioDynamics, Inc.,an affiliate or a subsidiary. All other trademarks are the property of their respective owners. ?2024 AngioDynamics, Inc. GL/VA/SM/2988 Rev 01 11/2024
关于我们
AngioDynamics is a leading, and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients. The Company’s innovative technologies and devices are chosen by talented physicians in fast-growing healthcare markets to treat unmet patient needs. https://www.angiodynamics.com/terms/
- 网站
-
https://www.angiodynamics.com/
AngioDynamics的外部链接
- 所属行业
- 医疗设备制造业
- 规模
- 501-1,000 人
- 总部
- Latham，New York
- 类型
- 上市公司
- 创立
- 1988
- 领域
- Endovascular Therapies、Medical Technology、Medical Devices、Atherectomy、Venous Insufficiency、Oncology和Vascular Access
地点
AngioDynamics员工
动态
-
Happy Rad Tech week! For more than 35 years, AngioDynamics has been supplying many of the key devices that you use daily. We would like to thank you for the vital role you play in our continued mission of improving patient care and outcomes. We see you. We appreciate you. We think you’re RAD! #RadTechWeek #NRTW2024 Risk Info: https://lnkd.in/gZpTgEYv
-
-
Pancreatic cancer accounts for about 3% of all cancers in the United States, with an average lifetime risk affecting 1 in 56 men and about 1 in 60 women. Early diagnosis is the key to allowing for more treatment options. At AngioDynamics, we are committed to raising awareness of Pancreatic Cancer and supporting clinical trials to develop new and effective treatment pathways. #PancreaticCancerAwareness #EarlyDetectionSavesLives #PurpleRibbon #PancreaticCancerResearch Reference: https://lnkd.in/gRaDxbQE
-
-
?? We’re excited to announce that Linda Upchurch, Vice President, Global Healthcare Economics, will be taking part in an insightful panel discussion on “Reimbursement, Rates & Revenue” at the LifeSciencesNY annual conference, Together ‘24. Her expertise and dedication to advancing healthcare innovation make her a valuable voice in navigating today’s complex reimbursement landscape. Join us in celebrating Linda’s contributions and insights as she represents our team on this important topic! ?? #TeamSpotlight #Together24 #HealthcareInnovation #Reimbursement
We'll be presenting a panel discussion around "Reimbursement, Rates & Revenue" at our annual conference, Together '24. Looking forward to the insights from Courtney Burke and Roland Poirier, both of Sachs Policy Group; Kirsten Tullia of AdvaMed and Linda Upchurch of AngioDynamics. Join us in Rochester! Register here: https://lnkd.in/eU7_BTqM
-
-
?? Exciting News from AngioDynamics! ?? We’re thrilled to announce that the American Medical Association's CPT? Editorial Panel has granted Category I CPT? codes for Irreversible Electroporation (IRE) in treating tumors in the prostate or liver! This significant milestone enhances market access to the NanoKnife System and facilitates reimbursement for healthcare providers performing IRE ablation procedures. Starting January 1, 2026, these new codes will empower providers to offer patients this innovative and minimally invasive treatment option that preserves surrounding structures and tissue, expanding access and care across the country. Jim Clemmer, President and CEO, highlighted the achievement as a testament to our commitment to innovative patient care. Learn more about the CPT Code: https://lnkd.in/de5_m_Np Explore more about the NanoKnife System at nanoknife.com Contact Us: https://lnkd.in/gbXwCYKW Risk Info: https://lnkd.in/gFNG_pA *In the United States, the NanoKnife System has received a 510(k) clearance by the Food and Drug Administration for the surgical ablation of soft tissue. The NanoKnife System has not been cleared for the treatment or therapy of a specific disease or condition.
-
-
Today is #WorldThrombosisDay. On this day we recognize those affected by Thrombosis. Our team is committed to improving lives affected by one of the world’s most deadly diseases. Learn more at: www.worldthrombosisday.org. Risk Info: https://lnkd.in/gZpTgEYv #WTD2024 #BioFlo
-
-
On #WorldThrombosisDay, we recognize those affected by the overlooked and misunderstood condition of thrombosis – the formation of a blood clot in a blood vessel. This condition occurs in people of all ages, races, and ethnicities. Knowing the signs, symptoms, and types of thrombosis can help you and others understand if they are at higher risk. Learn more at https://lnkd.in/eA-4h9B5. At AngioDynamics, our team is committed to improving lives affected by one of the world’s most deadly diseases. Will you join us? #WTD24 #PERT #Thrombus #AlphaVac #Bloodclot
-
-
Our Interventional Devices Team is live at #ALVS24 in Chicago! We are at booth #219 - stop by to learn all that our EVLT portfolio offers.
-
-
The AngioDynamics team had a fantastic week at #PERT2024! We want to thank those who visited our booth and attended our AlphaVac PE Reception and our Breakfast Satellite Symposium. A special thank you to physicians?Pavan Kavali MD,?Sripal Bangalore MD, and?Mona Ranade, MD, for leading our reception, “The Future of PE Management: Exploring Catheter-Based Therapies & Data Imperatives.” Your dedication and commitment to advancing treatment options for patients with pulmonary embolism and embracing cutting-edge technologies like the?#AlphaVac?F18-85 System are inspiring. Congratulations to Physicians Seth I. Sokol , M.D., FSCAI, Brent Keeling, MD, Sabah Butty, MD, and David M. Zlotnick, MD, for leading a thought-provoking discussion at our Breakfast Satellite Symposium, "Revolutionizing PE management: Insights into the AlphaVac F18-85 System". Your insights and expertise in PE treatment, as well as exploring the AlphaVac F18-85 System, are paving the way for innovative solutions and better patient outcomes. #AlphaVac #PulmonaryEmbolism #Thrombectomy #PERT2024 To learn more about the AlphaVac F18-85 System, visit www.alpha-vac.com Risk info: https://lnkd.in/gFNG_pA All physicians mentioned above are paid consultants of AngioDynamics. US/VI/SM/2923 Rev. 01. 09/2024
-